TMEM100 and pachyonychia congenita: TMEM100 exhibited a clear inhibition of metastasis and proliferation in lung cancer, prostate cancer (PC), hepatocellular carcinoma (HCC) and gastric cancer (GC), and is correlated with the prognostic outcomes of above malignancies (5–11).